Spyre Therapeutics, Inc. (SYRE)

SEC filing

Spyre Therapeutics, Inc.

SYRE · CIK 1636282

4 · Sep 3, 2026 · Director, Chief Executive Officer Turtle Cameron sold 15K shares at $87.29/share ($1.3M)

Director, Chief Executive Officer Turtle Cameron sold 15K shares at $87.29/share ($1.3M)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.